Exact Mass: 712.2621

Exact Mass Matches: 712.2621

Found 31 metabolites which its exact mass value is equals to given mass value 712.2621, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(-)-Syringaresnol 4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside

(-)-Syringaresnol 4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside

C33H44O17 (712.2578)


(-)-Syringaresnol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside is isolated from the bark of Albizia julibrissin[1]. (-)-Syringaresnol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside is isolated from the bark of Albizia julibrissin[1]. (-)-Syringaresnol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside is isolated from the bark of Albizia julibrissin[1]. (-)-Syringaresnol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside is isolated from the bark of Albizia julibrissin[1].

   

(+)-medioresinol 4,4-O-di-beta-D-glucopyranoside|(+)-medioresinol di-O-beta-D-glucopyranoside|(+)-medioresinol-di-O-beta-D-glucopyranoside|(+)-Medioresinol-di-O-beta-D-glucoside|medioresinol di-O-beta-D-glucopyranoside

(+)-medioresinol 4,4-O-di-beta-D-glucopyranoside|(+)-medioresinol di-O-beta-D-glucopyranoside|(+)-medioresinol-di-O-beta-D-glucopyranoside|(+)-Medioresinol-di-O-beta-D-glucoside|medioresinol di-O-beta-D-glucopyranoside

C33H44O17 (712.2578)


   

Syringaresinol-4-O-??-D-apiofuranosyl-(1鈥樏傗垎2)-??-D-glucopyranoside

Syringaresinol-4-O-??-D-apiofuranosyl-(1鈥樏傗垎2)-??-D-glucopyranoside

C33H44O17 (712.2578)


   

(+)-medioresinol di-O-beta-D-glucopyranoside

(+)-medioresinol di-O-beta-D-glucopyranoside

C33H44O17 (712.2578)


   

4-O-(6-O-beta-D-apiofuranosyl-beta-D-glucopyranosyl)-(+)-(7S,7S,8R,8R)-4-hydroxy-3,3,5,5-tetramethoxy-7,9:7,9-diepoxylignane|obtusifoside A

4-O-(6-O-beta-D-apiofuranosyl-beta-D-glucopyranosyl)-(+)-(7S,7S,8R,8R)-4-hydroxy-3,3,5,5-tetramethoxy-7,9:7,9-diepoxylignane|obtusifoside A

C33H44O17 (712.2578)


   

bis<4-(beta-D-glucopyranosyloxy)benzyl> (S)-(-)-2-isopropylmalate|bis[4-(beta-D-glucopyranosyloxy)benzyl] (S)-(-)-2-isopropylmalate

bis<4-(beta-D-glucopyranosyloxy)benzyl> (S)-(-)-2-isopropylmalate|bis[4-(beta-D-glucopyranosyloxy)benzyl] (S)-(-)-2-isopropylmalate

C33H44O17 (712.2578)


   

trachelogenin 4-O-beta-gentiobioside|trachelogenin beta-gentiobioside

trachelogenin 4-O-beta-gentiobioside|trachelogenin beta-gentiobioside

C33H44O17 (712.2578)


   
   

Trachelogenin 4-O-β-gentiobioside

Trachelogenin 4 inverted exclamation marka-O-|A-gentiobioside

C33H44O17 (712.2578)


Trachelogenin 4-O-beta-gentiobioside is a natural product found in Trachelospermum asiaticum and Trachelospermum jasminoides with data available.

   

(+)-Medioresinol Di-O-β-D-glucopyranoside

(2S,3R,4S,5S,6R)-2-[4-[(3R,3aS,6R,6aS)-6-[3,5-dimethoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C33H44O17 (712.2578)


   

(2R,3S,4S,5R,6S)-5-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-6-[4-[(3R,6S)-3-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2,6-dimethoxyphenoxy]-2-(hydroxymethyl)oxane-3,4-diol

NCGC00385303-01!(2R,3S,4S,5R,6S)-5-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-6-[4-[(3R,6S)-3-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2,6-dimethoxyphenoxy]-2-(hydroxymethyl)oxane-3,4-diol

C33H44O17 (712.2578)


   

Casopitant mesylate

Casopitant mesylate

C31H39F7N4O5S (712.2529)


D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Casopitant mesylate (GW679769B) is a potent, selective, brain permeable and orally active neurokinin 1 (NK1) receptor antagonist. Casopitant mesylate is a second in the class of antiemetics that acts to antagonise the emetogenic effect of substance P. Casopitant mesylate is also a substrate and a weak-to-moderate inhibitor of CYP3A4. Casopitant mesylate can be used for chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea and vomiting (PONV)[1][2].

   

L-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-gamma-glutamyl-L-gamma-glutamyl-

L-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-gamma-glutamyl-L-gamma-glutamyl-

C30H36N10O11 (712.2565)


   

2-[5-[6-[3,5-Dimethoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

2-[5-[6-[3,5-Dimethoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C33H44O17 (712.2578)


   

(2R,3S,4S,5R,6S)-5-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-6-[4-[(3R,6S)-3-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2,6-dimethoxyphenoxy]-2-(hydroxymethyl)oxane-3,4-diol

(2R,3S,4S,5R,6S)-5-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-6-[4-[(3R,6S)-3-(4-hydroxy-3,5-dimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-2,6-dimethoxyphenoxy]-2-(hydroxymethyl)oxane-3,4-diol

C33H44O17 (712.2578)


   
   

2-{2,6-dimethoxy-4-[4-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-hexahydrofuro[3,4-c]furan-1-yl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{2,6-dimethoxy-4-[4-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-hexahydrofuro[3,4-c]furan-1-yl]phenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H44O17 (712.2578)


   

(2s)-2-hydroxy-2-isopropyl-3,3-bis[(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]butanedioic acid

(2s)-2-hydroxy-2-isopropyl-3,3-bis[(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl]butanedioic acid

C33H44O17 (712.2578)


   

2-{2,6-dimethoxy-4-[4-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-hexahydrofuro[3,4-c]furan-1-yl]phenoxy}-6-methoxyoxane-3,4,5-triol

2-{2,6-dimethoxy-4-[4-(3-methoxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-hexahydrofuro[3,4-c]furan-1-yl]phenoxy}-6-methoxyoxane-3,4,5-triol

C33H44O17 (712.2578)


   

(3s,4s)-4-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-3-[(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}phenyl)methyl]oxolan-2-one

(3s,4s)-4-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-3-[(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}phenyl)methyl]oxolan-2-one

C33H44O17 (712.2578)


   

(2r,3r,4s,5s,6s)-2-{4-[(1s,3ar,4s,6ar)-4-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-6-methoxyoxane-3,4,5-triol

(2r,3r,4s,5s,6s)-2-{4-[(1s,3ar,4s,6ar)-4-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-6-methoxyoxane-3,4,5-triol

C33H44O17 (712.2578)


   

(2s,3r,4s,5s,6r)-2-{4-[(1s,3ar,4s,6ar)-4-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-{4-[(1s,3ar,4s,6ar)-4-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C33H44O17 (712.2578)


   

5-{[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-6-{4-[4-(4-hydroxy-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-2-(hydroxymethyl)oxane-3,4-diol

5-{[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-6-{4-[4-(4-hydroxy-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-2-(hydroxymethyl)oxane-3,4-diol

C33H44O17 (712.2578)


   

[(1r,3as,3bs,5s,5as,7s,8s,9as,11ar)-1-[(2r)-4-(1-isopropyl-2-methylcyclopropyl)butan-2-yl]-3a,9a,11a-trimethyl-7,8-bis(sulfooxy)-1h,2h,3h,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-5-yl]oxidanesulfonic acid

[(1r,3as,3bs,5s,5as,7s,8s,9as,11ar)-1-[(2r)-4-(1-isopropyl-2-methylcyclopropyl)butan-2-yl]-3a,9a,11a-trimethyl-7,8-bis(sulfooxy)-1h,2h,3h,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-5-yl]oxidanesulfonic acid

C31H52O12S3 (712.2621)


   

4-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-3-[(3-methoxy-4-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}phenyl)methyl]oxolan-2-one

4-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-3-[(3-methoxy-4-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}phenyl)methyl]oxolan-2-one

C33H44O17 (712.2578)


   

(2r,3s,4s,5r,6s)-6-{4-[(1r,3as,4s,6as)-4-(4-hydroxy-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-5-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-2-(hydroxymethyl)oxane-3,4-diol

(2r,3s,4s,5r,6s)-6-{4-[(1r,3as,4s,6as)-4-(4-hydroxy-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-5-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-2-(hydroxymethyl)oxane-3,4-diol

C33H44O17 (712.2578)


   

(2r,3s,4s,5r,6s)-6-{4-[(1r,3as,4r,6as)-4-(4-hydroxy-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-5-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-2-(hydroxymethyl)oxane-3,4-diol

(2r,3s,4s,5r,6s)-6-{4-[(1r,3as,4r,6as)-4-(4-hydroxy-3,5-dimethoxyphenyl)-hexahydrofuro[3,4-c]furan-1-yl]-2,6-dimethoxyphenoxy}-5-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-2-(hydroxymethyl)oxane-3,4-diol

C33H44O17 (712.2578)


   

1,4-bis[(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl] (2s)-2-hydroxy-2-isopropylbutanedioate

1,4-bis[(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl] (2s)-2-hydroxy-2-isopropylbutanedioate

C33H44O17 (712.2578)


   

[(1r,3as,5s,7s,8s,9as,11ar)-1-[4-(1-isopropyl-2-methylcyclopropyl)butan-2-yl]-3a,9a,11a-trimethyl-7,8-bis(sulfooxy)-1h,2h,3h,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-5-yl]oxidanesulfonic acid

[(1r,3as,5s,7s,8s,9as,11ar)-1-[4-(1-isopropyl-2-methylcyclopropyl)butan-2-yl]-3a,9a,11a-trimethyl-7,8-bis(sulfooxy)-1h,2h,3h,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-5-yl]oxidanesulfonic acid

C31H52O12S3 (712.2621)


   

1,4-bis[(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl] 2-hydroxy-2-isopropylbutanedioate

1,4-bis[(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl] 2-hydroxy-2-isopropylbutanedioate

C33H44O17 (712.2578)